Inhaled nitric oxide

Respiratory Care Clinics of North America

Volumn 8, Issue 2, 2002, Pages 261-279

  Hurford, William E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; VASODILATOR AGENT; ZAPRINAST;

ACUTE RESPIRATORY FAILURE; ADULT; ANIMAL; BLOOD DISEASE; BRONCHODILATING ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; HEMODYNAMICS; HUMAN; HYPOXEMIA; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG EDEMA; LUNG HEMORRHAGE; METHEMOGLOBINEMIA; NEWBORN; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY DISTRESS SYNDROME; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; NEONATAL RESPIRATORY DISTRESS SYNDROME;

ADMINISTRATION, INHALATION; ANIMALS; CLINICAL TRIALS; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; NITRIC OXIDE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0035986995     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5337(02)00008-4     Document Type: Article

References (114)

1. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
2. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
3. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn
4. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
5. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
6. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
7. Diagnosis and assessment of pulmonary hypertension
8. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
9. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
10. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
11. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension
12. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease
13. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension
14. Nitric oxide inhalation in infants with respiratory distress syndrome
15. Response of premature infants with severe respiratory failure to inhaled nitric oxide
16. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia
17. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial
18. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: A randomised controlled trial
19. Inhaled nitric oxide for the adult respiratory distress syndrome
20. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
21. Physiologic determinants of the response to inhaled nitric oxide in patients with the acute respiratory distress syndrome
22. Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome
23. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
24. Inhaled nitric oxide versus conventional therapy. Effect on oxygenation in ARDS
25. Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study
26. A double-blind, randomized placebo controlled study of 5 ppm inhaled nitric oxide in acute respiratory distress syndrome (ARDS)
27. Pulmonary hypertension in severe acute respiratory failure
28. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome
29. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
30. Open up the lung and keep the lung open
31. Causes of mortality in patients with the adult respiratory distress syndrome
32. The adult respiratory distress syndrome. A report of survival and modifying factors
33. Prevention of reperfusion injury by inhaled nitric oxide in lungs harvested from non-heart-beating donors
34. Inhaled nitric oxide for the acute respiratory distress syndrome
35. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation
36. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation
37. Inhaled nitric oxide reduces human lung allograft dysfunction
38. Inhaled nitric oxide for adult respiratory distress syndrome after pulmonary resection
39. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation
40. Inhaled nitric oxide: Selective pulmonary vasodilation in cardiac surgical patients
41. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension
42. Nitric oxide. Biology and pathobiology
43. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation
44. Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood
45. Inhaled nitric oxide in congenital heart disease
46. Effects of oxygen and nitric oxide in oxygen on pulmonary arterial pressures of children with congenital cardiac defects
47. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease
48. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension
49. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension
50. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects
51. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension
52. Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation
53. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
54. Low doses of inhaled nitric oxide in heart transplant recipients
55. Primary pulmonary hypertension: Executive summary from the world symposium-primary pulmonary hypertension 1998
56. Medical management of primary pulmonary hypertension
57. Chronic use of inhaled nitric oxide for pulmonary hypertension
58. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin
59. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension
60. It is time to consider domiciliary nitric oxide?
61. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension
62. Effects of inhaled nitric oxide on gas exchange in lungs with shunt or poorly ventilated areas
63. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease
64. Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension
65. Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease
66. Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease
67. The effect of low-dose inhalation of nitric oxide in patients with pulmonary fibrosis
68. Inhalation of nitric oxide modulates adult human bronchial' tone
69. Inhaled nitric oxide: A bronchodilator in mild asthmatics with methacholine-induced bronchospasm
70. The effect of inhaled nitric oxide in pediatric asthma
71. Bronchodilator effect of inhaled nitric oxide in healthy men
72. Inhaled nitric oxide for high-altitude pulmonary edema
73. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo
74. Inhaled nitric oxide in sickle cell disease with acute chest syndrome
75. Inhaled nitric oxide improves survival rates during hypoxia in a sicle cell (SAD) mouse model
76. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia
77. Effects of higher oxides of nitrogen on the anesthetized dog
78. Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction
79. Delivery of inhaled nitric oxide using the Ohmeda INOvent delivery system
80. Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxide
81. Low levels of nitric oxide as contaminant in hospital compressed air: Physiologic significance?
82. Bleeding time prolongation and NO inhalation
83. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome
84. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction
85. Hemodynamic effects of inhaled nitric oxide in heart failure
86. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure
87. Prolonged inhalation of low concentrations of oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation
88. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure
89. Toxicity and complications of inhaled nitric oxide
90. The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide
91. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease
92. Inhalation of nitric oxide in acute lung injury: Preliminary results of a European multicenter study
93. Response to nitric oxide inhalation in early acute lung injury
94. Lack of efficacy of inhaled nitric oxide in ARDS
95. Efficacy of inhaled nitric oxide in patients with severe ARDS
96. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome
97. Effectiveness of nitric oxide inhalation in septic ARDS
98. Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats
99. New insights into mechanisms underlying nitrate tolerance
100. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanisms underlying tolerance and cross-tolerance
101. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure
102. Inhaled nitric oxide in acute respiratory failure in adults
103. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury
104. ABO blood groupand inhaled nitric oxide in acute respiratory distress syndrome
105. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome
106. Positive end-expiratory pressure and response to inhaled nitric oxide: Changing nonresponders to responders
107. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury
108. The combination of partial liquid ventilation and inhaled nitric oxide in the severe oleic acid lung injury model
109. Partial liquid ventilation combined with inhaled nitric oxide in acute respiratory failure with pulmonary hypertension in piglets
110. Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome
111. Does norepinephrine modify the effects' of inhaled nitric oxide in septic patients with acute respiratory distress syndrome?
112. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs
113. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension
114. Sildenafil can increase the response to inhaled nitric oxide